Basking Ridge, NJ, United States of America

Raghunathan V Nair

This inventor holds 1 USPTO granted patent. Top assignee: Anaquest, Inc.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raghunathan V Nair. Retrieved from https://idiyas.com/inventor/raghunathan-v-nair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raghunathan V Nair: Innovator in Pharmaceutical Chemistry

Introduction

Raghunathan V Nair is a notable inventor based in Basking Ridge, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address medical conditions.

Latest Patents

Raghunathan V Nair holds a patent for "Derivatives of 4,5,6,7-tetrahydroimidazo-[4,5-c]pyridinyl-6-carboxylic." This invention pertains to a method for treating nausea and vomiting in mammals. The patent describes a method that involves administering a therapeutically effective amount of a specific derivative, which is represented by a complex chemical formula.

Career Highlights

Nair is currently associated with Anaquest, Inc., where he continues to work on innovative solutions in the pharmaceutical sector. His expertise in chemistry and drug formulation has positioned him as a valuable asset in his field.

Collaborations

Some of his notable coworkers include Danging D Feng and Tamara B Latham, who contribute to the collaborative efforts at Anaquest, Inc. Their combined expertise enhances the innovative capabilities of the company.

Conclusion

Raghunathan V Nair's work exemplifies the impact of innovation in pharmaceutical chemistry, particularly through his patented methods for treating nausea and vomiting. His contributions continue to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…